TAILIEUCHUNG - Tuning the performance of CAR T cell immunotherapies

Simultaneous advances in gene editing, T cell engineering and biotechnology currently provide an opportunity for rapid progress in medicine. The approval of chimeric antigen receptor (CAR) T cell therapies by the US Food and Drug Administration (FDA) and the European Commission have generated substantial momentum for these first-in-class therapies to be used in patients with B cell malignancies. | Richardson et al. BMC Biotechnology 2019 19 84 https s12896-019-0576-9 BMC Biotechnology REVIEW Open Access Tuning the performance of CAR T cell immunotherapies Check for updates Noah H. Richardson Jordan B. Luttrell Jonathan S. Bryant Damian Chamberlain Saleem Khawaja Indira Neeli and Marko Radic Abstract Background Simultaneous advances in gene editing T cell engineering and biotechnology currently provide an opportunity for rapid progress in medicine. The approval of chimeric antigen receptor CAR T cell therapies by the US Food and Drug Administration FDA and the European Commission have generated substantial momentum for these first-in-class therapies to be used in patients with B cell malignancies. Main body Considerable efforts focus on improved outcomes and reduced side effects of the newly approved therapies. Using innovative strategies researchers aim to extend CAR T cell use to tackle difficulties inherent in solid tumors. Efforts are underway to broaden the applications of CAR T cells and the strategy has been successful in chronic viral infections and preclinical models of autoimmunity. Research is in progress to generate off-the-shelf CAR T cells an advance which would greatly increase patient availability and reduce treatment cost. Conclusions In this thematic review we highlight advances that may help develop genetically engineered cells into a new category of medical therapies. Keywords Immunotherapy CAR T cells Chimeric antigen receptors Cancer Autoimmunity Background The remarkable success of CAR T cells in cancer patients who had failed to respond to standard treatments has captured the attention of researchers and the public at large 1 . The emergence of CAR T cells as therapeutic options with proven efficacy for B cell cancers is bolstered by the complete remission seen in most patients and the years of sustained efficacy that are possible. Potentially serious side effects although deserving of continued attention are largely .

• Sinh học
• BMC Biotechnology
• CAR T cells
• Chimeric antigen receptors
• Drug Administration
• European Commission
• Transgenic animals
• Recombinant proteins
• Animal biotechnology
• Functional cytokines
• ABC transporter
• Taxonomic diversity
• ATP binding cassette
• Transporter gene superfamily
• Community engagement
• Agricultural biotechnology
• Tissue culture
• Global health
• Global development
• Stakeholder engagement
• BMC Chemistry
• Citric acid
• White biotechnology
• Organic acid
• Emerging bioeconomy
• MicroRNAs
• cDNA synthesis
• synthetic templates
• Design of PCR primers
• Quantitative PCR
• Error prone PCR
• Site directed mutation
• Site saturation mutagenesis
• Catalytic efficiency
• Tobacco stalk
• Nicotine degradation
• Phanerochaete chrysosporium
• Lignocellulolytic enzymes
• Chaetomium globosum
• Synergistic action
• Lignocellulosic materials
• Phenolic alcohols
• β xylosidase
• Highly thermostable GH39
• Geobacillus sp
• Hydrolyzing xylo oligosaccharides
• Heterologous expression
• Kluyveromyces lactis
• Baking industry
• Plectosphaerella cucumerina
• Gelatin scaffold
• Human articular chondrocytes
• Extracellular matrix
• Cartilage tissue engineering
• Protein design
• Protein expression
• Protein interaction
• Protein engineering
• Pseudomonas putida strains
• Raw glycerol
• PHA depolymerase
• Metabolic engineering
• Protein cross linking
• Protein stability
• Baculovirus expression vector system
• Human influenza strain
• Arteriovenous loop
• PHD inhibitor
• Dimethyloxallyl Glycine
• HIF α level
• Substitution pattern
• Hydroxypropyl methylcellulose
• Application of carbohydrate binding modules
• Hydroxyethyl cellulose
• Rhizomucor pusillus
• α amylase
• Co expression
• Pichia pastoris
• Alkaline phosphatase
• Escherichia coli
• Psychrophilic alkaline phosphatase
• Hydrolytic cleavage
• Leuconostoc citreum
• Inulosucrase IslA
• Multidomain fructosyltransferase
• Multidomain enzyme
• Hydrolytic activity
• CD spectroscopy
• Homology modelling
• Peroxidase activity
• Superoxide dismutase
• Trichoderma reesei
• Endoglucanase I
• Cell free synthesis
• Saccharomyces cerevisiae
• Neurospora crassa
• Glutaminyl cylcase
• Tobacco mosaic virus
• Protein purification
• N benthamiana
• Active pharmaceutical ingredient
• Adenoviral vector
• Inducible vector
• Gene therapy
• Optimizing therapeutic outcomes
• Co transformation
• Gaussia princeps luciferase gene
• Genetic engineering
• Green algae
• Inducible promoter
• Nitrate reductase
• Spider silk
• Synthetic spidroin
• Atomic force microscopy
• Outstanding mechanical